Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-14580

ABSTRACT: Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

OTHER RELATED OMICS DATASETS IN: PRJNA113623PRJNA111695

PROVIDER: E-GEOD-14580 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-14580-analysis-methods.tsv	Tabular
	E-GEOD-14580-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-14580-configuration.xml	Xml
	E-GEOD-14580-percentile-ranks.tsv	Tabular
	E-GEOD-14580.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 68

Similar Datasets

E-GEOD-65114

Project description:Microarray analysis of colonic mucosal biopsies from healthy controls and patients with active ulcerative colitis

2025-01-24 | E-GEOD-65114 | ExpressionAtlas

E-GEOD-23597

Project description:Expression data from colonic biopsy samples of infliximab treated ulcerative colitis patients

2025-01-24 | E-GEOD-23597 | ExpressionAtlas

E-GEOD-57945

Project description:RNA-seq of 359 treatment-naive pediatric patients with Crohn's disease, patients with ulcerative colitis and control individuals

2019-05-14 | E-GEOD-57945 | ExpressionAtlas

E-GEOD-2461

Project description:Transcription profiling of mucosa from human patients with irritable bowel syndrome or ulcerative colitis

2025-01-24 | E-GEOD-2461 | ExpressionAtlas

Mucosal expression profiling in patients with inflammatory bowel disease before and after first infliximab treatment

Project description:We used microarrays to identify mucosal gene signatures predictive of response to infliximab (IFX) in patients with inflammatory bowel disease (IBD) and to gain more insight into the pathogenesis of IBD. Keywords: drug response and treatment effect Mucosal biopsies were obtained at endoscopy in actively inflamed mucosa from 61 IBD patients (24 ulcerative colitis (UC), 19 Crohnâs colitis (CDc) and 18 Crohnâs ileitis (CDi)), refractory to corticosteroids and/or immunosuppression, before and 4-6 weeks after (except for 1 CDc patient) their first infliximab infusion and in normal mucosa from 12 control patients (6 colon and 6 ileum). The patients were classified for response to infliximab based on endoscopic and histologic findings at 4-6 weeks after first infliximab treatment. Total RNA was isolated from intestinal mucosal biopsies, labelled and hybridized to Affymetrix Human Genome U133 Plus 2.0 Arrays.

2009-11-02 | E-GEOD-16879 | biostudies-arrayexpress

Microarray analysis of colonic mucosal biopsies from healthy controls and patients with active ulcerative colitis

Project description:Expression data was used to evaluate changes to the transcriptional signatures across the healthy and inflamed colon. A comparison between healthy controls and active ulcerative colitis signatures was also made. Mucosal biopsy specimens were harvested at four anatomical locations within the colon from healthy volunteers and patients with active ulcerative colitis. specimens were fixed in RNA later for 24 hours at room temperature and stored at -80C for a further 24 hours prior to RNA extraction and microarray analysis.

2015-01-21 | E-GEOD-65114 | biostudies-arrayexpress

E-GEOD-6731

Project description:Transcription profiling by array of human colon biosies from patients with Crohn's disease and ulcerative colitis

2025-01-24 | E-GEOD-6731 | ExpressionAtlas

Host-microbiome response to hyperbaric oxygen treatment in ulcerative colitis

Project description:Pre- and post-hyperbaric oxygen sequencing of mucosal biopsies of ulcerative colitis patients to understand host response to hyperoxia

2025-02-19 | GSE152229 | GEO

Homo sapiens

Project description:Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

| PRJNA111695 | ENA

E-GEOD-65270

Project description:Microarray analysis from paired biopsies from ileal pouch-anal anastomosis surgery patients with ulcerative colitis and familial adenomatous polyposis

2025-01-24 | E-GEOD-65270 | ExpressionAtlas

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data